yingweiwo

GnRH Receptor

GnRH Receptor

GnRH Receptor related products

Structure Cat No. Product Name CAS No. Product Description
(D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH V75391 (D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH 1926163-38-3 (D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH is an analog of luteinizing hormone-releasing hormone (LHRH).
[D-Ala6]-LH-RH V75389 [D-Ala6]-LH-RH 51230-19-4 [D-Ala6]-LH-RH is a luteinizing hormone-releasing hormone (LHRH) analog that works as a GnRH receptor agonist (activator).
GnRH-R antagonist 1 V75388 GnRH-R antagonist 1 2826273-90-7 GnRH-R antagonist 1 (compound 21a) is a GnRH-R antagonist (inhibitor) with good oral safety and membrane permeability.
Phoenixin-14 (PNX-14) V75383 Phoenixin-14 (PNX-14) 1415039-79-0 Phoenixin-14 (PNX-14) is an endogenous active isoform that produces anxiolytic effects by activating the mouse AHA GnRH system.
WAY-207024 V115806 WAY-207024 872002-72-7 WAY-207024 is an orally administered potent gonadotropin-releasing hormone receptor (GnRH-R) antagonist (human GnRH: IC50 12 nM, rat GnRH: IC50 71 nM).
噁拉戈利 V2801 ELAGOLIX 834153-87-6 Elagolix (formerly NBI56418; ABT620; NBI-56418; ABT-620; trade name: Orilissa) is a potent, specific, orally bioavailable, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) used for pain management.
安替肽 V50930 Antide acetate 625092-10-6 gonadotropin-releasing hormone receptor antagonist
恶拉戈利钠 V3881 Elagolix sodium 832720-36-2 Elagolix sodium (NBI56418; ABT-620; Orilissa), the sodium salt of Elagolix, is an orally bioavailable and small molecule antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (KD = 54 pM) approved on 7/23/2018 by FDA for the management of moderate to severe pain associated with endometriosis.
Contact Us